N-(CARBOXYMETHYL)-N-(PHOSPHONOMETHYL)-GLYCINE, 95%, 1kg

4-(4-ethoxyphenyl)-3-(pyridin-3-yl)-4,5-dihydro-1H-1,2,4-triazole-5-thione, 97%, 100mg

2-(isobutylsulfonyl)ethanamine, 95.0%, 1g

6-Ethoxy-1,3-benzothiazole-2-thiol, 97.0%, 1g

2,4-Dichloro-7-fluoro-5H-pyrrolo[3,2-d]pyrimidine, 95+%, 100mg

[(1-pyrimidin-2-ylpiperidin-4-yl)methyl]amine, 95.0%, 500mg

(2R,4R)-4-FLUOROPYRROLIDINE-2-CARBOXYLIC ACID HCL, 95.0%, 1g

N,N-dimethylaniline, >=99%, for synthesis, 1L, glass packaging

[1,1'-Biphenyl]-4,4'-diyldiboronic acid, 95.0%, 25g

ethyl 1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidine-4-carboxylate, 250mg

5-Benzo[1,3]dioxol-5-yl-1 H -pyrazole-3-carboxylic acid methyl ester, 5g

Ethyl [1,2,4]triazolo[4,3-a]pyrimidine-3-carboxylate, 95.0%, 100mg

2-Bromo-6-tert-butyloxy-pyridine, 97.0%, 1g